Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Journal of Inflammation|January 1, 1995
Regional application of TNF alpha in the treatment of cancer: a preclinical-clinical interactive programA M Eggermont, E R Manusama, T L ten Hagen
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1996
Isolated limb perfusion with TNF alpha and melphalan in a rat osteosarcoma model: a new anti-tumour approachE R Manusama, J Stavast, N M Durante, et al.
The British Journal of Surgery|April 1, 1996
Synergistic antitumour effect of recombinant human tumour necrosis factor alpha with melphalan in isolated limb perfusion in the ratE R Manusama, P T Nooijen, J Stavast, et al.
Oncology Reports|December 29, 1998
Toxicity and antitumor activity of interferon gamma alone and in combinations with TNFalpha and melphalan in isolated limb perfusion in the BN175 sarcoma tumor model in ratsE R Manusama, J H De Wilt, T L Ten Hagen, et al.
The Journal of Surgical Research|September 12, 1998
Assessment of the role of neutrophils on the antitumor effect of TNFalpha in an in vivo isolated limb perfusion model in sarcoma-bearing brown Norway ratsE R Manusama, P T Nooijen, J Stavast, et al.
British Journal of Cancer|December 1, 1996
Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical studyP T Nooijen, E R Manusama, A M Eggermont, et al.
British Journal of Cancer|July 2, 1999
Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in ratsJ H de Wilt, E R Manusama, S T van Tiel, et al.
Trauma Surgery & Acute Care Open|October 1, 2024
Resuscitative endovascular balloon occlusion of the aorta (REBOA) for non-trauma patients in an urban hospital: a series of two casesJan C van de Voort, Suzanne M Vrancken, Eric R Manusama, et al.
British Journal of Cancer|October 12, 2000
Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusionsJ H de Wilt, E R Manusama, B van Etten, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 21, 1999
Isolated limb perfusion with tumour necrosis factor-alpha and melphalan for unresectable bone sarcomas of the lower extremityJ Bickels, E R Manusama, M Gutman, et al.
Pageof 4